Pacific Biosciences of California, Inc. Share Price
Stocks
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.445 USD | +1.76% |
|
+3.24% | -23.26% |
| Market Cap | 441M 383M 358M 329M 619M 42.04B 630M 4.22B 1.65B 20.96B 1.66B 1.62B 69.15B | P/E 2026 * |
-3.41x | P/E 2027 * | -3.01x |
|---|---|---|---|---|---|
| Enterprise Value | 441M 383M 358M 329M 619M 42.04B 630M 4.22B 1.65B 20.96B 1.66B 1.62B 69.15B | EV / Sales 2026 * |
2.63x | EV / Sales 2027 * | 2.27x |
| Free-Float |
91.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | +1.06% | ||
| 1 week | +3.24% | ||
| Current month | +2.50% | ||
| 1 month | -13.55% | ||
| 3 months | -7.42% | ||
| 6 months | -26.41% | ||
| Current year | -23.26% |
| 1 week | 1.38 |  | 1.49 |
| 1 month | 1.32 | | 1.72 |
| Current year | 1.09 | | 2.73 |
| 1 year | 1.09 | | 2.73 |
| 3 years | 0.85 | | 12.53 |
| 5 years | 0.85 | | 35.58 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christian Henry
CEO | Chief Executive Officer | 58 | 13/09/2020 |
Jim Gibson
DFI | Director of Finance/CFO | 57 | 30/03/2025 |
Mark van Oene
COO | Chief Operating Officer | 53 | 07/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 31/12/2003 |
Randy Livingston
BRD | Director/Board Member | 72 | 31/12/2008 |
Marshall Mohr
BRD | Director/Board Member | 69 | 17/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/06/26 | Free | Director | 74,497 | 0.0240% | ||
| 27/02/26 | Free | Controller/Auditor | 269,505 | 0.0893% | ||
| 27/02/26 | Free | Chief Financial Officer | 1,001,544 | 0.3317% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | +3.24% | +3.24% | -88.22% | 441M | |
| -1.62% | -1.77% | +21.36% | +3.21% | 212B | |
| -1.75% | -2.15% | -1.36% | -23.54% | 139B | |
| -2.00% | +2.08% | -23.60% | +19.40% | 133B | |
| +0.66% | +5.93% | -54.31% | -3.81% | 70.19B | |
| +0.10% | +6.11% | +10.87% | +11.62% | 51.14B | |
| -0.20% | +9.27% | -15.12% | -20.37% | 50.09B | |
| -1.44% | -2.08% | +19.88% | +9.00% | 39.48B | |
| +3.60% | +1.56% | +36.52% | +34.50% | 36.79B | |
| -0.16% | +2.82% | +101.57% | +5.73% | 29.92B | |
| Average | -0.17% | +4.02% | +9.91% | -5.25% | 76.18B | |
| Weighted average by Cap. | -0.96% | +3.55% | +3.11% | +1.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 167M 146M 136M 125M 235M 15.96B 239M 1.6B 627M 7.96B 629M 615M 26.25B | 194M 169M 158M 145M 273M 18.52B 278M 1.86B 728M 9.23B 730M 714M 30.46B |
| Net income | -131M -114M -106M -97.47M -184M -12.47B -187M -1.25B -490M -6.22B -491M -481M -20.51B | -153M -133M -124M -114M -214M -14.54B -218M -1.46B -572M -7.25B -573M -560M -23.92B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/08/26 | US$1.435 | +1.06% | 1,560,711 |
| 03/08/26 | US$1.420 | +1.43% | 3,553,631 |
| 31/07/26 | US$1.400 | -5.41% | 3,139,195 |
| 30/07/26 | US$1.480 | +5.71% | 2,807,842 |
| 29/07/26 | US$1.400 | +0.72% | 7,337,925 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
